WO2010094986A1 - Préparation de caroténoïde micronisé en tant qu'immunostimulant pour les crustacés - Google Patents

Préparation de caroténoïde micronisé en tant qu'immunostimulant pour les crustacés Download PDF

Info

Publication number
WO2010094986A1
WO2010094986A1 PCT/IB2009/000291 IB2009000291W WO2010094986A1 WO 2010094986 A1 WO2010094986 A1 WO 2010094986A1 IB 2009000291 W IB2009000291 W IB 2009000291W WO 2010094986 A1 WO2010094986 A1 WO 2010094986A1
Authority
WO
WIPO (PCT)
Prior art keywords
zeaxanthin
formula
formulation
formulation according
represent
Prior art date
Application number
PCT/IB2009/000291
Other languages
English (en)
Inventor
Mario David Torres Cardona
Gonzales Danilo Vizcarra
Original Assignee
Innova Andina S.A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innova Andina S.A filed Critical Innova Andina S.A
Priority to PCT/IB2009/000291 priority Critical patent/WO2010094986A1/fr
Priority to PE2010000081A priority patent/PE20100697A1/es
Priority to CL2010000130A priority patent/CL2010000130A1/es
Publication of WO2010094986A1 publication Critical patent/WO2010094986A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Definitions

  • LPS lipopolysaccharide
  • PG peptidoglycan
  • IJ insulin receptor 1 :60-65
  • immunostimulants are widely used in the shrimp culture industry at present, there are several unsolved issues concerning their field application. For example, the interactive effects between different types of immunostimulants and the beneficial effects of combining them with other nutrients like the carotenoides.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention concerne des caroténoïdes micronisés dans un véhicule huileux ; la composition agit en tant qu'immunostimulant pour des crustacés.
PCT/IB2009/000291 2009-02-18 2009-02-18 Préparation de caroténoïde micronisé en tant qu'immunostimulant pour les crustacés WO2010094986A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PCT/IB2009/000291 WO2010094986A1 (fr) 2009-02-18 2009-02-18 Préparation de caroténoïde micronisé en tant qu'immunostimulant pour les crustacés
PE2010000081A PE20100697A1 (es) 2009-02-18 2010-02-04 Preparacion de una formulacion util como coadyuvante de inmunoestimulantes y fuente de pigmentos para crustaceos
CL2010000130A CL2010000130A1 (es) 2009-02-18 2010-02-16 Formulacion que comprende carotenoides libres y esterificados de extractos de marigold, paprika o aceite de palma en una suspension oleosa, en que los cristales tienen un tamaño de 0,1 a 2 u.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2009/000291 WO2010094986A1 (fr) 2009-02-18 2009-02-18 Préparation de caroténoïde micronisé en tant qu'immunostimulant pour les crustacés

Publications (1)

Publication Number Publication Date
WO2010094986A1 true WO2010094986A1 (fr) 2010-08-26

Family

ID=42633448

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2009/000291 WO2010094986A1 (fr) 2009-02-18 2009-02-18 Préparation de caroténoïde micronisé en tant qu'immunostimulant pour les crustacés

Country Status (3)

Country Link
CL (1) CL2010000130A1 (fr)
PE (1) PE20100697A1 (fr)
WO (1) WO2010094986A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001067896A2 (fr) * 2000-03-17 2001-09-20 Basf Aktiengesellschaft Procede pour la production de suspensions huileuses de vitamines solubles dans l'eau
WO2003105807A1 (fr) * 2002-06-18 2003-12-24 Zeavision Llc Zeaxanthine microcristalline a biodisponibilite elevee dans des formulations de support huileuses
WO2004018417A1 (fr) * 2002-08-26 2004-03-04 Kancor Flavours And Extracts Ltd Procede ameliore pour la preparation de cristaux de xanthophylle
EP1460060A1 (fr) * 2001-12-28 2004-09-22 Antibioticos, S.A. Procede permettant d'obtenir de nouvelles formulations a base de luteine
WO2006034556A1 (fr) * 2004-09-29 2006-04-06 Michael Ary Bos Composition carotenoide et sa methode de preparation
US20080107768A1 (en) * 2006-09-29 2008-05-08 Industrial Organica, S.A. De C.V. Method for increasing the health condition of crustaceans in aquaculture

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001067896A2 (fr) * 2000-03-17 2001-09-20 Basf Aktiengesellschaft Procede pour la production de suspensions huileuses de vitamines solubles dans l'eau
EP1460060A1 (fr) * 2001-12-28 2004-09-22 Antibioticos, S.A. Procede permettant d'obtenir de nouvelles formulations a base de luteine
WO2003105807A1 (fr) * 2002-06-18 2003-12-24 Zeavision Llc Zeaxanthine microcristalline a biodisponibilite elevee dans des formulations de support huileuses
WO2004018417A1 (fr) * 2002-08-26 2004-03-04 Kancor Flavours And Extracts Ltd Procede ameliore pour la preparation de cristaux de xanthophylle
WO2006034556A1 (fr) * 2004-09-29 2006-04-06 Michael Ary Bos Composition carotenoide et sa methode de preparation
US20080107768A1 (en) * 2006-09-29 2008-05-08 Industrial Organica, S.A. De C.V. Method for increasing the health condition of crustaceans in aquaculture

Also Published As

Publication number Publication date
PE20100697A1 (es) 2010-10-03
CL2010000130A1 (es) 2010-05-28

Similar Documents

Publication Publication Date Title
Lorenz et al. Commercial potential for Haematococcus microalgae as a natural source of astaxanthin
Berman et al. Nutritionally important carotenoids as consumer products
Breithaupt Modern application of xanthophylls in animal feeding–a review
Marounek et al. Use of carotenoids in feed mixtures for poultry: a review
Sousa et al. Microalgae in novel food products
Higuera-Ciapara et al. Astaxanthin: a review of its chemistry and applications
Sajilata et al. The carotenoid pigment zeaxanthin—a review
Cysewski et al. Industrial Production of Microalgal Cell‐Mass and Secondary Products‐Species of High Potential: Haematococcus
EP0718284B1 (fr) Cétones et esters caroténoiques
CA2529055C (fr) Absorption amelioree de nutriants liposolubles
Becker Microalgae for aquaculture: nutritional aspects
Ju et al. Pigmentation of Pacific white shrimp, Litopenaeus vannamei, by dietary astaxanthin extracted from Haematococcus pluvialis
KR101479821B1 (ko) 황반 색소를 함유하는 크산토필 조성물과 이의 제조 방법
Rodriguez-Amaya Carotenes and xanthophylls as antioxidants
Ritu et al. Utilization of astaxanthin from microalgae and carotenoid rich algal biomass as a feed supplement in aquaculture and poultry industry: An overview
US6783951B2 (en) Process for production of carotenoids, xanthophylls and apo-carotenoids utilizing eukaryotic microorganisms
Çalışlar The important of beta carotene on poultry nutrition
Curubay et al. Effects of adding spirulina platensis to laying hen rations on performance, egg quality, and some blood parameters
Sales et al. Effects of dietary use of two lipid extracts from the microalga Nannochloropsis gaditana (Lubián, 1982) alone and in combination on growth and muscle composition in juvenile gilthead seabream, Sparus aurata
Dansou et al. Carotenoid enrichment in eggs: from biochemistry perspective
Shi et al. Sources, dynamics in vivo, and application of astaxanthin and lutein in laying hens: A review
Li et al. Effects of different carotenoids on pigmentation of blood parrot (Cichlasoma synspilum× Cichlasoma citrinellum)
Chow et al. The effect of dietary carotenoids of different forms: microemulsified and non-microemulsified on the growth performance, pigmentation and hematological parameters in hybrid catfish (Clarias macrocephalus× Clarias gariepinus)
Singh et al. Emergence of plants in fish pigmentation
JP5559447B2 (ja) カロテノイドエステル

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09840263

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09840263

Country of ref document: EP

Kind code of ref document: A1